These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2350767)

  • 21. [Restenosis after angioplasty. Diagnosis and treatment].
    Steg PG; Aubry P
    Presse Med; 1995 Dec; 24(38):1825-30. PubMed ID: 8545435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restenosis following coronary angioplasty: clinical presentations and therapeutic options.
    Levine GN; Chodos AP; Loscalzo J
    Clin Cardiol; 1995 Dec; 18(12):693-703. PubMed ID: 8608668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Restenosis after coronary angioplasty: 30 per 100 only...].
    Cherrier F; Danchin N
    Rev Prat; 1990 Jan; 40(2):137-9. PubMed ID: 2300770
    [No Abstract]   [Full Text] [Related]  

  • 24. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses.
    Haudenschild CC
    Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Restenosis, the Achilles heel of coronary angioplasty].
    Macaya C
    An Med Interna; 1991 Jan; 8(1):1-3. PubMed ID: 1912149
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical interventions for prevention and therapy of restenosis of coronary heart disease].
    Schanzenbächer P
    Verh Dtsch Ges Inn Med; 1991; 97():593-7. PubMed ID: 1808952
    [No Abstract]   [Full Text] [Related]  

  • 28. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
    Bauriedel G
    Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects and chronology of coronary restenosis after percutaneous transluminal coronary angioplasty. Quantitative angiographic analysis at 1, 2, 3, 4 and 5 months].
    Koning R; Luijten HE; Beatt KJ; Leborgne O; Suryapranata H; van den Brand M; de Feyter PJ; Serruys PW
    Arch Mal Coeur Vaiss; 1989 Feb; 82(2):177-84. PubMed ID: 2525369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design considerations in the study of restenosis after percutaneous transluminal coronary angioplasty.
    Weintraub WS
    Am J Cardiol; 1987 Jul; 60(3):3B-4B. PubMed ID: 2956838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restenosis following coronary angioplasty.
    Karas SP; Santoian EC; Gravanis MB
    Clin Cardiol; 1991 Oct; 14(10):791-801. PubMed ID: 1954687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of restenosis after PTCA--a statistical problem].
    Lechleitner P
    Dtsch Med Wochenschr; 1991 May; 116(22):877. PubMed ID: 2036952
    [No Abstract]   [Full Text] [Related]  

  • 33. Restenosis following coronary angioplasty.
    Fanelli C; Aronoff R
    Am Heart J; 1990 Feb; 119(2 Pt 1):357-68. PubMed ID: 2405612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study.
    Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P
    Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical promise of calcium antagonists in the angioplasty patient.
    Thaulow E; Jörgensen B
    Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.
    Nobuyoshi M; Kimura T; Ohishi H; Horiuchi H; Nosaka H; Hamasaki N; Yokoi H; Kim K
    J Am Coll Cardiol; 1991 Feb; 17(2):433-9. PubMed ID: 1991900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience.
    Roubin GS; King SB; Douglas JS
    Am J Cardiol; 1987 Jul; 60(3):39B-43B. PubMed ID: 2956840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Southwestern internal medicine conference: restenosis: the Achilles heel of coronary angioplasty.
    Lange RA; Willard JE; Hillis LD
    Am J Med Sci; 1993 Oct; 306(4):265-75. PubMed ID: 8213896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous transluminal coronary angioplasty restenosis: potential prevention with laser balloon angioplasty.
    Spears JR
    Am J Cardiol; 1987 Jul; 60(3):61B-64B. PubMed ID: 2956846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormone therapy as a therapeutic option in prevention of restenosis after angioplasty? Analysis of estrogen and progesterone receptors in human coronary plaque cells in vitro].
    Voisard R; Seitzer U; Hannekum A; Kochs M; Hombach V; Böhm W
    Vasa Suppl; 1992; 35():130-1. PubMed ID: 1481016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.